-+ 0.00%
-+ 0.00%
-+ 0.00%

*C4 Therapeutics Had Cash, Cash Equivalents and Marketable Securities of $268.3M as of March 31, With Cash Runway to the End of 2028 >CCCC

Dow Jones·05/12/2026 11:08:00

Please log in to view news